Tekla Kalalo, - and Andang Miatmoko, - and Hanafi Tanojo, - and Tristiana Erawati, - and Dewi Melani Hariyadi, - and Noorma Rosita, - (2022) Effect of Sodium Alginate Concentration on Characteristics, Stability and Drug Release of Inhalation Quercetin Microspheres. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 9 (2). pp. 107-114. ISSN 2580-8303
![[img]](https://repository.unair.ac.id/style/images/fileicons/text.png) |
Text (FULLTEXT)
C-26 Artikel.pdf Download (4MB) |
|
Text (KUALITAS KARIL)
C-26 Kualitas Karil.pdf Download (506kB) |
|
Text (SIMILARITY)
C-26 Similarity.pdf Download (2MB) |
Abstract
Background: Quercetin is a flavonoid compound that has anti-inflammation activity. However, poor stability presents significant problems for the formulation into dosage forms. Microspheres are one of the potential lung delivery systems because of their ability to encapsulate various types of drugs, protect drugs from environmental effects and can release drugs in a sustained release. Objective: In the present study, the microsphere inhalation system of the anti-inflammation drug, quercetin was developed and evaluated to achieving the targeted delivery of these drugs to the lung. Method: The drug-loaded ca-alginate microspheres were prepared by aerosolization ionic gelation technique followed by freeze-drying. Result: The result of this study showed that particle size was less than 2 µm, the yield ranged from 41.33-76.14%, drug loading was less than 6%, entrapment efficiency ranged from 74.153% - 93.805% and flow properties showed that all formula had an excellent flow. Spherical microspheres were demonstrated by formulations containing 1 and 1.5% sodium alginate. A drug release study showed that the highest drug release of 30.649% was from the formulation with 2.5% sodium alginate, and the lowest drug release of 26.625% was from the formulation with 2% sodium alginate. , A stability study at temperatures of 25ᵒC and 40ᵒC for 28 days showed a decrease in drug loading and entrapment efficiency but an increase in particle size. The formulation containing 1.5% sodium alginate showed the optimal formula. Conclusion: These findings indicated that quercetin ca-alginate microspheres are the potential for inhalation to be delivered to the lung. 1, 2, 3, 2, 2, 2
| Item Type: | Article | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uncontrolled Keywords: | Aashigari, S., Goud, R. G. & Raju Potnuri, N. (2019). Stability Studies of Pharmaceutical Products. World Journal of Pharmaceutical Research; 8; 479-492. doi: 10.20959/wjpr20191-13872. Alipour, S., Montaseri, H. & Tafaghodi, M. (2010). Preparation and Characterization of Biodegradable Paclitaxel Loaded Alginate Microparticles for Pulmonary Delivery. Colloids and Surfaces B: Biointerfaces; 81; 521–529. doi: 10.1016/j.colsurfb.2010.07.050. Athamneh, T., Amin, A., Benke, E., Ambrus, R., Leopold, C. S., Gurikov, P. & Smirnova, I. (2019). Alginate and Hybrid Alginate-Hyaluronic Acid Aerogel Microspheres as Potential Carrier for Pulmonary Drug Delivery. Journal of Supercritical Fluids; 150; 49–55. doi: 10.1016/j.supflu.2019.04.013. Cunico, L. P., Cobo, A. M., Al-Hamimi, S. & Turner, C. (2020). Solubility and Thermal Degradation of Quercetin in Co2-Expanded Liquids. Molecules; 25; 1-10. doi: 10.3390/molecules25235582. Hariyadi, D. M. & Hendradi, E. (2020a). Optimization Performance and Physical Stability of Ciprofloxacin HCLCA Alginate Microspheres: Effect of Different Concentration of Alginate and CACL2. International Journal of Drug Delivery Technology; 10; 89–94. Hariyadi, D. M. & Hendradi, E. (2020b). Optimization Performance and Physical Stability of Ciprofloxacin HCLCA Alginate Microspheres: Effect of Different Concentration of Alginate and CACL2. International Journal of Drug Delivery Technology; 10; 89–94. Hariyadi, D. M., Hendradi, E. & Kurniawan, T. D. (2019). Alginate Microspheres Encapsulating Ciprofloxacin HCl: Characteristics, Release and Antibacterial Activity. International Journal of Pharma Research and Health Sciences; 7; 3020–3027. doi: 10.21276/ijprhs.2019.04.02. Hazra, M., Dasgupta, M. D., Mandal, T., Bhuniya, S. & Ghosh, M. (2015). Designing Polymeric Microparticulate Drug Delivery System for Hydrophobic Drug Quercetin. Saudi Pharmaceutical Journal; 23; 429–436. doi: 10.1016/j.jsps.2015.01.007. Huang, R., Zhong, T. & Wu, H. (2015). Quercetin Protects Against Lipopolysaccharide-Induced Acute Lung Injury in Rats Through Suppression of Inflammation and Oxidative Stress. Archives of Medical Science; 11; 427–432. doi: 10.5114/aoms.2015.50975. Kumar, K. R. & Suresh, G. (2018). Development and Characterization of Alginate Microspheres Containing Olmesartan by Ionotropic Gelation Method. International Journal of Pharmaceutical Sciences and Drug Research; 10; 335-341. doi: 10.25004/IJPSDR.2018.100420. Kyzioł, A., Mazgała, A., Michna, J., Regiel-Futyra, A., & Sebastian, V. (2017). Preparation and Characterization of Alginate/Chitosan Formulations for Ciprofloxacin-Controlled Delivery. Journal of Biomaterials Applications; 32; 162–174. doi: 10.1177/0885328217714352. Paranjpe, M. & Müller-Goymann, C. C. (2014). Nanoparticle-Mediated Pulmonary Drug Delivery: a Review. International Journal of Molecular Sciences; 15; 5852–5873. doi: 10.3390/ijms15045852.. Saeedi-Boroujeni, A. & Mahmoudian-Sani, M. R. (2021). Anti-Inflammatory Potential of Quercetin in COVID-19 Treatment. Journal of Inflammation (United Kingdom); 18; 1-9. Soni, M. L., Kumar, M. & Namdeo, K. P. (2010). Sodium Alginate Microspheres for Extending Drug Release: Formulation and In Vitro Evaluation. International Journal of Drug Delivery; 2; 64–68. doi: :10.5138/ijdd.2010.0975.0215.02013. Uyen, N. T. T., Hamid, Z. A. A., Tram, N. X. T. & Ahmad, N. (2020). Fabrication of Alginate Microspheres for Drug Delivery: a Review. International Journal of Biological Macromolecules; 153; 1035–1046. doi: 10.1016/j.ijbiomac.2019.10.233. Vishwa, B., Moin, A., Gowda, D. V., Rizvi, S. M. D., Hegazy, W. A. H., Abu Lila, A. S., Khafagy, E. S. & Allam, A. N. (2021). Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis. Pharmaceutics; 13; 1–17. doi: 10.3390/pharmaceutics13010079. | ||||||||||||||
| Subjects: | R Medicine R Medicine > RS Pharmacy and materia medica R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica R Medicine > RS Pharmacy and materia medica > RS200-201 Pharmaceutical dosage forms |
||||||||||||||
| Divisions: | 05. Fakultas Farmasi > Farmastika | ||||||||||||||
| Creators: |
|
||||||||||||||
| Depositing User: | Mr M. Fuad Sofyan | ||||||||||||||
| Date Deposited: | 17 Apr 2023 00:08 | ||||||||||||||
| Last Modified: | 17 Apr 2023 00:08 | ||||||||||||||
| URI: | http://repository.unair.ac.id/id/eprint/123759 | ||||||||||||||
| Sosial Share: | |||||||||||||||
Actions (login required)
 |
View Item |